Collection
Key companies and platforms working across gene editing, engineered cells, vectors, and therapy enablement.
profluent.bio
An AI-first protein design company using generative models for novel proteins and gene-editing systems.
beamtx.com
A biotechnology company focused on precision gene editing and base-editing therapeutics.
intelliatx.com
Intellia Therapeutics advances in vivo and ex vivo CRISPR/Cas9 genome editing therapies for genetic diseases. Tailored for modern biology and life science teams.
cariboubio.com
A gene-editing biotechnology company focused on CRISPR-based cell therapy and therapeutic development.
synthego.com
Synthego provides CRISPR genome engineering tools, kits, and engineered cells to accelerate gene editing research. Tailored for modern biology and life science teams.
This collection currently includes 7 indexable resources, making it useful when you want a practical set of related options around one workflow or theme.
Key companies and platforms working across gene editing, engineered cells, vectors, and therapy enablement. The collection emphasizes how those resources fit together, not just how they exist as isolated entries.
Cell and gene therapy is fragmented across tools, suppliers, and platform companies. This collection turns that sprawl into a more usable shortlist.
Use it for market scans, vendor discovery, and future editorial roundups around CRISPR, vectors, and manufacturing support.
